# A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis

> **NCT00002159** · PHASE3 · COMPLETED · sponsor: **Janssen, LP** · enrollment: 60 (—)

## Conditions studied

- HIV Infections
- Histoplasmosis
- Blastomycosis

## Interventions

- **DRUG:** Itraconazole
- **DRUG:** Amphotericin B

## Key facts

- **NCT ID:** NCT00002159
- **Lead sponsor:** Janssen, LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002159, "A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00002159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*